Physician
Chen, Helen (Min)
Chen, Helen (Min) was paid $2.91M by Medicaid between Jan 2018 and Dec 2024, across 135 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 13% of everything it billed.
33Billing provider infoCHEN, HELEN (MIN)
PALOS HEIGHTS, IL 60463
PALOS HEIGHTS, IL 60463
33aNPI1124028022assigned 07/21/2005
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.91M
24GClaims585,242
24DCodes billed135
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#21 of 398
Median peer was paid$66K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 59,799 | $212K | |
| 2019 | 72,897 | $256K | |
| 2020 | 83,795 | $337K | |
| 2021 | 88,936 | $468K | |
| 2022 | 96,965 | $667K | |
| 2023 | 95,846 | $555K | |
| 2024incomplete | 87,004 | $415K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 13% | 75,145 | 48,513 | $385K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.4% | 6,701 | 5,480 | $245K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.8% | 79,090 | 48,838 | $227K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.1% | 2,327 | 1,991 | $147K |
| 83735 | 4.0% | 35,115 | 15,758 | $115K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.7% | 26,686 | 11,031 | $109K |
| 84484 | 3.6% | 26,065 | 18,400 | $105K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 3.5% | 523 | 481 | $103K |
| 83880 | 2.8% | 7,714 | 6,010 | $82K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.8% | 3,421 | 2,992 | $81K |
| 87040 | 2.7% | 7,275 | 5,612 | $79K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.4% | 3,129 | 2,980 | $69K |
123 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 2.1% | 7,750 | $62K |
| 84703 | 2.1% | 17,515 | $62K | |
| 85027 | 2.1% | 21,523 | $61K | |
| 83690 | 1.9% | 16,328 | $55K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.6% | 1,453 | $47K |
| 83605 | 1.5% | 8,604 | $45K | |
| 85730 | 1.5% | 14,231 | $44K | |
| 82962 | 1.5% | 27,818 | $43K | |
| 85610 | 1.2% | 18,403 | $35K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 6,393 | $32K |
| 84100 | 1.0% | 14,966 | $30K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.0% | 537 | $30K |
| 85379 | 1.0% | 7,834 | $29K | |
| 80305 | <1% | 3,342 | $29K | |
| 80306 | <1% | 4,327 | $27K | |
| 82803 | <1% | 3,587 | $26K | |
| 82805 | <1% | 1,144 | $24K | |
| 81001 | <1% | 16,592 | $22K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 835 | $19K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 832 | $19K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 826 | $18K |
| 86850 | <1% | 6,213 | $18K | |
| 87186 | <1% | 2,974 | $18K | |
| 84145 | <1% | 2,597 | $17K | |
| 87641 | <1% | 721 | $16K | |
| 86901 | <1% | 6,727 | $15K | |
| 80061 | Lipid panel | <1% | 4,331 | $15K |
| 84702 | <1% | 3,325 | $15K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 585 | $14K |
| 82607 | <1% | 2,401 | $14K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,913 | $13K |
| 81003 | <1% | 11,636 | $12K | |
| 86900 | <1% | 6,726 | $11K | |
| 82550 | <1% | 4,302 | $11K | |
| 82728 | <1% | 2,780 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,428 | $11K |
| 82746 | <1% | 1,814 | $10K | |
| 87070 | <1% | 3,122 | $10K | |
| 87205 | <1% | 4,787 | $9K | |
| 80202 | <1% | 1,295 | $9K | |
| 87081 | <1% | 3,009 | $9K | |
| 86140 | <1% | 3,717 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,051 | $8K |
| 84439 | <1% | 1,939 | $8K | |
| 85007 | <1% | 4,471 | $8K | |
| 82077 | <1% | 710 | $7K | |
| 87507 | <1% | 41 | $7K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 40 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 471 | $7K |
| 83540 | <1% | 1,947 | $6K | |
| 83550 | <1% | 1,358 | $6K | |
| 83615 | <1% | 1,996 | $5K | |
| 85652 | <1% | 3,983 | $5K | |
| 82140 | <1% | 1,061 | $5K | |
| 87340 | <1% | 610 | $4K | |
| 87481 | <1% | 118 | $4K | |
| 87075 | <1% | 532 | $3K | |
| 82570 | <1% | 1,412 | $3K | |
| 81025 | <1% | 953 | $2K | |
| 86706 | <1% | 347 | $2K | |
| 82248 | <1% | 1,214 | $2K | |
| 84466 | <1% | 449 | $2K | |
| 80076 | <1% | 532 | $2K | |
| 80074 | <1% | 92 | $2K | |
| 88342 | <1% | 93 | $2K | |
| 82553 | <1% | 461 | $2K | |
| 88307 | <1% | 14 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 31 | $1K |
| 87634 | <1% | 48 | $1K | |
| 89051 | <1% | 381 | $1K | |
| 87077 | <1% | 429 | $1K | |
| 86038 | <1% | 141 | $1K | |
| 86803 | <1% | 124 | $1K | |
| 85018 | <1% | 919 | $1K | |
| 83930 | <1% | 404 | $946.50 | |
| 81015 | <1% | 911 | $901.78 | |
| 87147 | <1% | 307 | $866.90 | |
| 84550 | <1% | 447 | $858.16 | |
| 86480 | <1% | 34 | $857.71 | |
| 85014 | <1% | 713 | $781.08 | |
| 80069 | <1% | 187 | $764.61 | |
| 87581 | <1% | 33 | $755.70 | |
| 87486 | <1% | 32 | $732.80 | |
| 86308 | <1% | 264 | $628.32 | |
| 82977 | <1% | 245 | $608.87 | |
| 82947 | <1% | 199 | $531.55 | |
| 83970 | <1% | 33 | $513.48 | |
| 82565 | <1% | 248 | $512.54 | |
| 80164 | <1% | 108 | $480.81 | |
| 84156 | <1% | 340 | $395.28 | |
| 85384 | <1% | 124 | $377.00 | |
| 86592 | <1% | 181 | $364.00 | |
| 84300 | <1% | 165 | $349.48 | |
| 85060 | <1% | 56 | $312.78 | |
| 83520 | <1% | 35 | $310.66 | |
| 82009 | <1% | 235 | $291.46 | |
| 82247 | <1% | 75 | $173.08 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 12 | $171.96 |
| 86431 | <1% | 46 | $166.52 | |
| 82043 | <1% | 83 | $158.68 | |
| 85045 | <1% | 94 | $126.23 | |
| 86762 | <1% | 29 | $125.21 | |
| 82150 | <1% | 38 | $120.50 | |
| 87116 | <1% | 17 | $111.15 | |
| 86705 | <1% | 14 | $107.80 | |
| 87449 | <1% | 14 | $102.61 | |
| 86701 | <1% | 14 | $80.74 | |
| 83090 | <1% | 12 | $79.20 | |
| 86920 | <1% | 25 | $77.43 | |
| 86225 | <1% | 13 | $76.70 | |
| 87088 | <1% | 12 | $67.50 | |
| 87015 | <1% | 16 | $57.60 | |
| 87102 | <1% | 17 | $52.70 | |
| 84132 | <1% | 14 | $45.00 | |
| 86880 | <1% | 13 | $37.70 | |
| 82950 | <1% | 12 | $27.96 | |
| 84157 | <1% | 14 | $16.80 | |
| 80346 | 0% | 258 | $0.00 | |
| 80361 | 0% | 262 | $0.00 | |
| 80329 | 0% | 148 | $0.00 | |
| 80353 | 0% | 43 | $0.00 | |
| 80320 | 0% | 3,917 | $0.00 | |
| 80349 | 0% | 327 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.